Applied DNA eyes big things in latest small package
By GREGORY ZELLER // At first glance, it may seem like a minor acquisition, but stay tuned – when Applied DNA Sciences makes “minor acquisitions,” seismic industrial shifts tend to…
LineaRx
How to stop COVID, and maybe whatever comes next
By GREGORY ZELLER // The latest DNA-based advance by a progressive Long Island biotech goes where other biochemists have gone before – but also blazes a trail for new vaccination…
No. 722: A fall kickoff with Farrah Gray, football and some fine boxed wine – and an important JFK arrival
Are you ready for some football? Welcome to Friday, friends, as we finish the first workweek of September and hunker down for a decidedly autumnal weekend – complete with…
No. 711: What’s up, Doc? We’ve got best hospitals, crème brûlée and the all-time king of the sitcoms
Here and gone: Welcome to Wednesday, dear readers, as we slide into the second half of another summery workweek. Before we do, this quick scheduling reminder: Innovate Long Island…
Beefing up cancer treatments, with a vaccine in sight
By GREGORY ZELLER // New vaccines produced in part by a progressive Long Island biotech could significantly increase the efficacy of existing cancer treatments. The potential breakthrough – detailed this…
Science, numbers back Applied DNA’s COVID-19 serums
By GREGORY ZELLER // With scientists around the world racing toward a COVID-19 vaccine, serums manufactured by a Long Island biotech are showing significant promise – both medically and economically….
Applied DNA ups ante, again, with Clinical Labs spinoff
By GREGORY ZELLER // One of Long Island’s busiest biotechs has spun off another local startup, this time focused on testing its own potential breakthroughs. Stony Brook-based Applied DNA Sciences,…
LI biotech speeds COVID-19 vaccine candidates to Italy
By GREGORY ZELLER // With preliminary lab tests looking good, an innovative Long Island biotech is rushing a quintet of potential COVID-19 vaccines overseas. Stony Brook-based Applied DNA Sciences announced…
No. 486: On mega-moons, linear DNA and innovative immigrant services – and yes, lots of coronavirus stuff
The unusual: Welcome to Wednesday, dear readers, and the midpoint of another weird and wild workweek, as the Great Coronavirus Pandemic continues to reshape our world and the regional…
Island firm speeds coronavirus vaccines toward tests
By GREGORY ZELLER // Just weeks after announcing an expanded international collaboration targeting the menacing novel coronavirus, Applied DNA Sciences is preparing to mass-produce four potential vaccines. Leveraging the Stony…
No. 477: In which the Suffolk IDA incentivizes and the double helix debuts – plus, sticky buns for all!
Just a word or two: Welcome to Friday, dear readers, as we wrap up another busy workweek and look forward to another well-earned weekend. It’s Feb. 21 out there,…
Applied DNA to speed up coronavirus countermeasures
By GREGORY ZELLER // Look out, coronavirus – Applied DNA is coming for you. Adding to its growing portfolio of cutting-edge Polymerase Chain Reaction-based projects, Stony Brook-based Applied DNA Sciences…
‘Linear DNA’ combo shows punch in cancer fight
By GREGORY ZELLER // Mark another impressive victory for LineaRX, this time in a two-front battle against cancer. The Stony Brook-based biotech with innovation in its DNA (literally) has lent…
For Applied DNA, new blood – and a shot in the arm
By GREGORY ZELLER // Just 11 months after spinning off from its parent company, a Stony Brook startup with expansion in its DNA has made its first corporate acquisition. LineaRX,…
No. 349: Canada’s new high, Sikes’ new heights and LineaRX’s highest hopes (plus, repainting President Trump)
Middle ground: Welcome to Wednesday, dear readers, and the halfway point of another exciting week of socioeconomic innovation. October 17 is in full swing, marking the 25th anniversary of…